{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:38:44Z","timestamp":1779104324526,"version":"3.51.4"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ebiom.2024.105364","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T06:44:01Z","timestamp":1727678641000},"page":"105364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adults"],"prefix":"10.1016","volume":"108","author":[{"given":"Anneth","family":"Tumbo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freia-Raphaella","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie S.P.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Sefried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Mpina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Dangy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence A.","family":"Milando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3863-3212","authenticated-orcid":false,"given":"Mohammed A.","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Nyaulingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamaka","family":"Ramadhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Jongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip L.","family":"Felgner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonas","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. Kim Lee","family":"Sim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.W. Preston","family":"Church","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas L.","family":"Richie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter F.","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tooba","family":"Murshedkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Abdulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G.","family":"Kremsner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9101-2768","authenticated-orcid":false,"given":"Benjamin","family":"Mordm\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Daubenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4716-0311","authenticated-orcid":false,"given":"Rolf","family":"Fendel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2024.105364_bib1","series-title":"World malaria report 2013","year":"2013"},{"key":"10.1016\/j.ebiom.2024.105364_bib2","series-title":"World malaria report 2023","year":"2023"},{"key":"10.1016\/j.ebiom.2024.105364_bib3","article-title":"Malaria","volume":"3","author":"Phillips","year":"2017","journal-title":"Nat Rev Dis Prim"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105364_bib4","article-title":"malERA: an updated research agenda for basic science and enabling technologies in malaria elimination and eradication","volume":"14","author":"mal ERARCPoBS","year":"2017","journal-title":"PLoS Med"},{"issue":"09","key":"10.1016\/j.ebiom.2024.105364_bib5","first-page":"61","article-title":"Weekly epidemiological record, 2022, vol. 97, 09 [full issue]","volume":"97","author":"WHO","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.ebiom.2024.105364_bib6","series-title":"WHO preferred product characteristics (PPC) for malaria vaccines","year":"2014"},{"issue":"10426","key":"10.1016\/j.ebiom.2024.105364_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(23)02511-4","article-title":"Safety and efficacy of malaria vaccine candidate R21\/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial","volume":"403","author":"Datoo","year":"2024","journal-title":"Lancet"},{"issue":"10287","key":"10.1016\/j.ebiom.2024.105364_bib8","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(21)00943-0","article-title":"Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial","volume":"397","author":"Datoo","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105364_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-014719","article-title":"Policy uptake and implementation of the RTS,S\/AS01 malaria vaccine in sub-Saharan African countries: status 2 years following the WHO recommendation","volume":"9","author":"Osoro","year":"2024","journal-title":"BMJ Glob Health"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105364_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-023-04714-z","article-title":"Could vaccinating adults against malaria materially reduce adult mortality in high-transmission areas?","volume":"22","author":"Gelband","year":"2023","journal-title":"Malar J"},{"key":"10.1016\/j.ebiom.2024.105364_bib11","series-title":"Malaria vaccines: preferred product characteristics and clinical development considerations","year":"2022"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105364_bib12","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1080\/14760584.2023.2245890","article-title":"Sporozoite immunization: innovative translational science to support the fight against malaria","volume":"22","author":"Richie","year":"2023","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105364_bib13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s44321-024-00057-7","article-title":"A\u00a0replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion","volume":"16","author":"Goswami","year":"2024","journal-title":"EMBO Mol Med"},{"issue":"7642","key":"10.1016\/j.ebiom.2024.105364_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature21060","article-title":"Sterile protection against human malaria by chemoattenuated PfSPZ vaccine","volume":"542","author":"Mordm\u00fcller","year":"2017","journal-title":"Nature"},{"issue":"7866","key":"10.1016\/j.ebiom.2024.105364_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-021-03684-z","article-title":"Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity","volume":"595","author":"Mwakingwe-Omari","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105364_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22740-w","article-title":"Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial","volume":"12","author":"Sulyok","year":"2021","journal-title":"Nat Commun"},{"issue":"Pt 21","key":"10.1016\/j.ebiom.2024.105364_bib17","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1242\/jeb.00644","article-title":"Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine","volume":"206","author":"Luke","year":"2003","journal-title":"J\u00a0Exp Biol"},{"issue":"52","key":"10.1016\/j.ebiom.2024.105364_bib18","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.1016\/j.vaccine.2015.09.096","article-title":"Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines","volume":"33","author":"Richie","year":"2015","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105364_bib19","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1093\/cid\/ciz1152","article-title":"Increase of dose associated with decrease in protection against controlled human malaria infection by PfSPZ vaccine in Tanzanian adults","volume":"71","author":"Jongo","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105364_bib20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(17)30104-4","article-title":"Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial","volume":"17","author":"Sissoko","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105364_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1473-3099(21)00332-7","article-title":"Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial","volume":"22","author":"Sissoko","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105364_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124412","article-title":"HIV malaria Co-infection is associated with atypical memory B cell expansion and a reduced antibody response to a broad array of Plasmodium falciparum antigens in Rwandan adults","volume":"10","author":"Subramaniam","year":"2015","journal-title":"PLoS One"},{"issue":"7760","key":"10.1016\/j.ebiom.2024.105364_bib23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41586-019-1200-9","article-title":"Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017","volume":"570","author":"Dwyer-Lindgren","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105364_bib24","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.vaccine.2019.10.077","article-title":"Safety and immunogenicity of the RTS,S\/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa","volume":"38","author":"Otieno","year":"2020","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105364_bib25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1089\/apc.2014.0121","article-title":"Vaccination in HIV-infected adults","volume":"28","author":"Crum-Cianflone","year":"2014","journal-title":"AIDS Patient Care STDS"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105364_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169060","article-title":"Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults","volume":"134","author":"Jongo","year":"2024","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105364_bib27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/QCO.0000000000000193","article-title":"A\u00a0systems biology approach for diagnostic and vaccine antigen discovery in tropical infectious diseases","volume":"28","author":"Liang","year":"2015","journal-title":"Curr Opin Infect Dis"},{"issue":"15","key":"10.1016\/j.ebiom.2024.105364_bib28","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1073\/pnas.1001323107","article-title":"A\u00a0prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray","volume":"107","author":"Crompton","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"10.1016\/j.ebiom.2024.105364_bib29","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1002\/pmic.200800194","article-title":"Profiling humoral immune responses to P. falciparum infection with protein microarrays","volume":"8","author":"Doolan","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.ebiom.2024.105364_bib30","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1038\/srep03549","article-title":"Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis","volume":"3","author":"Felgner","year":"2013","journal-title":"Sci Rep"},{"issue":"32","key":"10.1016\/j.ebiom.2024.105364_bib31","doi-asserted-by":"crossref","first-page":"E4438","DOI":"10.1073\/pnas.1501705112","article-title":"Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities","volume":"112","author":"Helb","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2024.105364_bib32","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53080","article-title":"Proteome-wide analysis of a malaria vaccine study reveals personalized humoral immune profiles in Tanzanian adults","volume":"9","author":"Camponovo","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.ebiom.2024.105364_bib33","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69040","article-title":"Common virulence gene expression in adult first-time infected malaria patients and severe cases","volume":"10","author":"Wichers","year":"2021","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105364_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/mSphereDirect.00027-19","article-title":"Antibody biomarkers associated with sterile protection induced by controlled human malaria infection under chloroquine prophylaxis","volume":"4","author":"Obiero","year":"2019","journal-title":"mSphere"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105364_bib35","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/infdis\/jiv224","article-title":"Plasmodium falciparum protein microarray antibody profiles correlate with protection from symptomatic malaria in Kenya","volume":"212","author":"Dent","year":"2015","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105364_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41541-022-00473-1","article-title":"Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens","volume":"7","author":"Ibanez","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"3 Suppl","key":"10.1016\/j.ebiom.2024.105364_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4269\/ajtmh.15-0037","article-title":"Biosignatures of exposure\/transmission and immunity","volume":"93","author":"King","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105364_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/mSphereDirect.00061-19","article-title":"Distinct antibody signatures associated with different malaria transmission intensities in Zambia and Zimbabwe","volume":"4","author":"Kobayashi","year":"2019","journal-title":"mSphere"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105364_bib39","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41590-021-00911-7","article-title":"Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity","volume":"22","author":"de Jong","year":"2021","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105364_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201700277","article-title":"Antibody profiling by proteome microarray with multiplex isotype detection reveals overlap between human and Aotus nancymaae controlled malaria infections","volume":"18","author":"Taghavian","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.ebiom.2024.105364_bib41","series-title":"R: a language and environment for statistical computing [Computer software, version 3.6. 2]","year":"2019"},{"issue":"20","key":"10.1016\/j.ebiom.2024.105364_bib42","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/bioinformatics\/btm412","article-title":"A\u00a0comparison of background correction methods for two-colour microarrays","volume":"23","author":"Ritchie","year":"2007","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105364_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105364_bib44","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/biostatistics\/kxn042","article-title":"Microarray background correction: maximum likelihood estimation for the normal-exponential convolution","volume":"10","author":"Silver","year":"2009","journal-title":"Biostatistics"},{"key":"10.1016\/j.ebiom.2024.105364_bib45","series-title":"Proceedings of the SIGCHI conference on human factors in computing systems","first-page":"143","article-title":"The aligned rank transform for nonparametric factorial analyses using only anova procedures","author":"Wobbrock","year":"2011"},{"key":"10.1016\/j.ebiom.2024.105364_bib46","series-title":"ggplot 2: elegant graphics for data analysis","author":"Wickham","year":"2016"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105364_bib47","first-page":"1","article-title":"gplots: various R programming tools for plotting data","volume":"2","author":"Warnes","year":"2009","journal-title":"R\u00a0Package Version"},{"key":"10.1016\/j.ebiom.2024.105364_bib48","series-title":"Ggbeeswarm: Categorical scatter (violin point) plots","author":"Clarke","year":"2017"},{"key":"10.1016\/j.ebiom.2024.105364_bib49","volume":"3","author":"Edwards","year":"2019"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105364_bib50","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/bioinformatics\/btw037","article-title":"PAA: an R\/bioconductor package for biomarker discovery with protein microarrays","volume":"32","author":"Turewicz","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2024.105364_bib51","article-title":"Mapping of safe and early chemo-attenuated live Plasmodium falciparum immunization identifies immune signature of vaccine efficacy","author":"Borrmann","year":"2020","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105364_bib52","doi-asserted-by":"crossref","first-page":"e01170","DOI":"10.1128\/mBio.01170-19","article-title":"A\u00a0novel tool for the generation of conditional knockouts to study gene function across the Plasmodium falciparum life cycle","volume":"10","author":"Tib\u00farcio","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.ebiom.2024.105364_bib53","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fcimb.2020.00270","article-title":"Generation of novel Plasmodium falciparum NF135 and NF54 lines expressing fluorescent reporter proteins under the control of strong and\u00a0constitutive promoters","volume":"10","author":"Miyazaki","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ebiom.2024.105364_bib54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s12936-016-1393-4","article-title":"Common asymptomatic and submicroscopic malaria infections in Western Thailand revealed in longitudinal molecular and serological studies: a challenge to malaria elimination","volume":"15","author":"Baum","year":"2016","journal-title":"Malar J"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105364_bib55","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106583","article-title":"Zonal human hepatocytes are differentially permissive to Plasmodium falciparum malaria parasites","volume":"40","author":"Yang","year":"2021","journal-title":"EMBO J"},{"key":"10.1016\/j.ebiom.2024.105364_bib56","first-page":"123","article-title":"Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies","volume":"9","author":"Kwenti","year":"2018","journal-title":"Res Rep Trop Med"},{"issue":"14","key":"10.1016\/j.ebiom.2024.105364_bib57","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003205","article-title":"The effect of malaria and HIV Co-infection on anemia: a meta-analysis","volume":"95","author":"Naing","year":"2016","journal-title":"Medicine (Baltim)"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105364_bib58","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/432730","article-title":"Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi","volume":"192","author":"Patnaik","year":"2005","journal-title":"J\u00a0Infect Dis"},{"issue":"9235","key":"10.1016\/j.ebiom.2024.105364_bib59","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(00)02727-6","article-title":"Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study","volume":"356","author":"Whitworth","year":"2000","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105364_bib60","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/339409","article-title":"Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites","volume":"185","author":"Hoffman","year":"2002","journal-title":"J\u00a0Infect Dis"},{"issue":"6152","key":"10.1016\/j.ebiom.2024.105364_bib61","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.1241800","article-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","volume":"341","author":"Seder","year":"2013","journal-title":"Science"},{"issue":"7121","key":"10.1016\/j.ebiom.2024.105364_bib62","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nature05361","article-title":"The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites","volume":"444","author":"Kumar","year":"2006","journal-title":"Nature"},{"issue":"6055","key":"10.1016\/j.ebiom.2024.105364_bib63","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.1211548","article-title":"Live attenuated malaria vaccine designed to protect through hepatic CD8\u207a T cell immunity","volume":"334","author":"Epstein","year":"2011","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105364_bib64","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/infdis\/jiy080","article-title":"Immunization of malaria-Preexposed volunteers with PfSPZ vaccine elicits long-lived IgM invasion-inhibitory and complement-fixing antibodies","volume":"217","author":"Zenklusen","year":"2018","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105364_bib65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-6851(98)00045-0","article-title":"Close linkage of three merozoite surface protein genes on chromosome 2 of Plasmodium falciparum","volume":"94","author":"Marshall","year":"1998","journal-title":"Mol Biochem Parasitol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105364_bib66","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0166-6851(99)00134-6","article-title":"Lack of sequence diversity in the gene encoding merozoite surface protein 5 of Plasmodium falciparum","volume":"103","author":"Wu","year":"1999","journal-title":"Mol Biochem Parasitol"},{"issue":"21\u201322","key":"10.1016\/j.ebiom.2024.105364_bib67","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1016\/S0264-410X(03)00116-6","article-title":"The protective efficacy of MSP4\/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol","volume":"21","author":"Rainczuk","year":"2003","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105364_bib68","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1128\/IAI.70.12.6606-6613.2002","article-title":"Immunization with a combination of merozoite surface proteins 4\/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii","volume":"70","author":"Kedzierski","year":"2002","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105364_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101737","article-title":"Association of antibody responses to the conserved Plasmodium falciparum merozoite surface protein 5 with protection against clinical malaria","volume":"9","author":"Perraut","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2024.105364_bib70","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1186\/1471-2334-13-608","article-title":"Natural antibody response to Plasmodium falciparum merozoite antigens MSP5, MSP9 and EBA175 is associated to clinical protection in the Brazilian Amazon","volume":"13","author":"Medeiros","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105364_bib71","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fimmu.2019.00331","article-title":"A\u00a0synthetic nanoparticle based vaccine approach targeting MSP4\/5 is immunogenic and induces moderate protection against murine blood-stage malaria","volume":"10","author":"Wilson","year":"2019","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105364_bib72","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/IAI.00054-06","article-title":"A\u00a0set of glycosylphosphatidyl inositol-anchored membrane proteins of Plasmodium falciparum is refractory to genetic deletion","volume":"74","author":"Sanders","year":"2006","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105364_bib73","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89154","article-title":"Protection against Plasmodium falciparum malaria by PfSPZ vaccine","volume":"2","author":"Epstein","year":"2017","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105364_bib74","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158030","article-title":"Strong off-target antibody reactivity to malarial antigens induced by RTS,S\/AS01E vaccination is associated with protection","volume":"7","author":"Maci\u00e0","year":"2022","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105364_bib75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12916-019-1378-6","article-title":"RTS,S\/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study","volume":"17","author":"Doba\u00f1o","year":"2019","journal-title":"BMC Med"},{"issue":"5639","key":"10.1016\/j.ebiom.2024.105364_bib76","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1087025","article-title":"Discovery of gene function by expression profiling of the malaria parasite life cycle","volume":"301","author":"Le Roch","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105364_bib77","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1038\/s41467-019-12936-6","article-title":"Transcriptomics and proteomics reveal two waves of translational repression during the maturation of malaria parasite sporozoites","volume":"10","author":"Lindner","year":"2019","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105364_bib78","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1016\/j.celrep.2018.02.075","article-title":"A\u00a0specific PfEMP1 is expressed in P. Falciparum sporozoites and plays a role in hepatocyte infection","volume":"22","author":"Zangh\u00ec","year":"2018","journal-title":"Cell Rep"},{"issue":"13","key":"10.1016\/j.ebiom.2024.105364_bib79","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.celrep.2017.03.017","article-title":"Cell traversal activity is important for Plasmodium falciparum liver infection in humanized mice","volume":"18","author":"Yang","year":"2017","journal-title":"Cell Rep"},{"issue":"14","key":"10.1016\/j.ebiom.2024.105364_bib80","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1074\/jbc.M115.698282","article-title":"Multiple Plasmodium falciparum merozoite surface protein 1 complexes mediate merozoite binding to human erythrocytes","volume":"291","author":"Lin","year":"2016","journal-title":"J\u00a0Biol Chem"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105364_bib81","doi-asserted-by":"crossref","first-page":"eaax4489","DOI":"10.1126\/sciadv.aax4489","article-title":"IgM in human immunity to Plasmodium falciparum malaria","volume":"5","author":"Boyle","year":"2019","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105364_bib82","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12916-018-1054-2","article-title":"Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children","volume":"16","author":"Kurtovic","year":"2018","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105364_bib83","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41541-022-00510-z","article-title":"A\u00a0PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection","volume":"7","author":"Mordm\u00fcller","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105364_bib84","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nm.4513","article-title":"A\u00a0public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein","volume":"24","author":"Tan","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105364_bib85","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.immuni.2016.06.014","article-title":"Somatically hypermutated plasmodium-specific IgM(+) memory B cells are rapid, plastic, early responders upon malaria rechallenge","volume":"45","author":"Krishnamurty","year":"2016","journal-title":"Immunity"},{"issue":"28","key":"10.1016\/j.ebiom.2024.105364_bib86","doi-asserted-by":"crossref","first-page":"10311","DOI":"10.1073\/pnas.1409928111","article-title":"Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria","volume":"111","author":"Srinivasan","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2024.105364_bib87","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.3389\/fmicb.2018.03300","article-title":"Antibody responses to antigenic targets of recent exposure are associated with low-density parasitemia in controlled human Plasmodium falciparum infections","volume":"9","author":"van den Hoogen","year":"2019","journal-title":"Front Microbiol"},{"issue":"32","key":"10.1016\/j.ebiom.2024.105364_bib88","first-page":"4438","article-title":"Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities","volume":"112","author":"Helba","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105364_bib89","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4269\/ajtmh.16-0893","article-title":"Molecular markers for sensitive detection of Plasmodium falciparum asexual stage parasites and their application in a malaria clinical trial","volume":"97","author":"Tadesse","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105364_bib90","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4269\/ajtmh.17-0343","article-title":"Impact of sickle cell trait and naturally acquired immunity on uncomplicated malaria after controlled human malaria infection in adults in Gabon","volume":"98","author":"Lell","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105364_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004563","article-title":"Antibody profiling in na\u00efve and semi-immune individuals experimentally challenged withPlasmodium vivax sporozoites","volume":"10","author":"Ar\u00e9valo-Herrera","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105364_bib92","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1016\/S2352-3018(24)00035-3","article-title":"Uncovering HIV and malaria interactions: the latest evidence and knowledge gaps","volume":"11","author":"Figueroa-Romero","year":"2024","journal-title":"Lancet HIV"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105364_bib93","article-title":"Evidence of sociodemographic heterogeneity across the HIV treatment cascade and progress towards 90-90-90 in sub-Saharan Africa\u2013a systematic review and meta-analysis","volume":"23","author":"Green","year":"2020","journal-title":"J\u00a0Int AIDS Soc"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T02:33:21Z","timestamp":1729564401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424004006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":93,"alternative-id":["S2352396424004006"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105364","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adults","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105364"}}